Cape Town:The Portfolio Committee on Health has decided to convene privately to determine its next steps after the Department of Health did not respond to repeated warnings concerning a multibillion-rand antiretroviral (ARV) tender.
According to Parliament of South Africa, the decision follows a briefing by Health Minister Dr. Aaron Motsoaledi and senior officials on a High Court judgment that overturned parts of the ARV tender process due to significant flaws in contract evaluation and awarding.
Committee Chairperson Ms. Faith Muthambi emphasized the issue's importance, highlighting its impact on access to life-saving treatment for millions dependent on the public health system. The department acknowledged it would not appeal the judgment and accepted the need to review certain tender process aspects, while noting that some companies have filed appeals.
Committee members reiterated concerns raised in February about supplier capacity, alleged collusion, and inadequate due diligence, which the court has now validated. Members criticized basic procurement failures and called for stronger investigative measures, suggesting beyond ordinary departmental probes due to the severity of the allegations.
Ms. Michele Clarke questioned the oversight failures within the department, while Dr. Kgosi Letlape proposed a comprehensive commission to investigate potential insider trading. Ms. Naledi Chirwa-Mpungose criticized the Minister's inaction despite being informed of these issues, rejecting attempts to distance himself from the situation.
The committee expressed dissatisfaction with how the matter has been handled, stressing the need for accountability among officials who misled the Minister and Parliament. Ms. Muthambi criticized superficial compliance presentations and urged for immediate corrective actions against implicated officials.
The committee plans to meet in camera to further discuss the concerns and potential recommendations to address this critical public health issue.
Source Parliament of South Africa